Depressive symptomatology and quality of life assessment among women using the levonorgestrel-releasing intrauterine system: an observational study

Arch Gynecol Obstet. 2014 Sep;290(3):507-11. doi: 10.1007/s00404-014-3237-1. Epub 2014 Apr 19.

Abstract

Objective: The aim of our study was to examine the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) treatment on depressive symptoms, changes in bleeding patterns, and quality of life (QoL) among premenopausal women in our clinic.

Materials and methods: We recruited 120 premenopausal women, aged 18-50 years, who had sought care in the previous year for menorrhagia. LNG-IUS was inserted into eligible patients after the relevant evaluations. Both questionnaires were administered at time of the initial screening before and 6 months after insertion of the LNG-IUS. All patients completed the 36-item Short-Form Health Survey (SF-36) for QoL and Beck's Depression Inventory for depressive symptoms.

Results: At the 6-month follow-up visit, the pictorial blood assessment chart score (PBAC) considerably decreased (p < 0.001). For SF-36 scores, physical functioning, physical role limitations, emotional role limitations, bodily pain, vitality, and mental health scores improved significantly after treatment (p < 0.001). Depression scores showed no significant difference from baseline to 6 months (p = 0.375).

Conclusion: The LNG-IUS for the treatment of menorrhagia increases the QoL, and depression scores did not increase significantly in 6 months.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Contraceptive Agents, Female / administration & dosage*
  • Depression / epidemiology*
  • Female
  • Humans
  • Intrauterine Devices, Medicated*
  • Levonorgestrel / administration & dosage*
  • Menorrhagia / psychology
  • Menorrhagia / therapy*
  • Middle Aged
  • Quality of Life*
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Contraceptive Agents, Female
  • Levonorgestrel